Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company...
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company...
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- As the new year begins, it offers a meaningful moment to reflect on...